Rapid Critical Metals Limited (RCM) Fair Value & Analysis
Basic Materials · AU · Market cap A$43.1M
Fair value as of: Jun 26, 2026
Analysis
Rapid Critical Metals Limited (RCM) currently trades at A$0.0320, while our model-based Fair Value estimate is A$0.0250 — implying the stock looks roughly 22.0% overvalued today. We read business quality at 91/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Rapid Critical Metals Limited engages in the exploration and evaluation of mineral resource properties in Africa, the United States, and internationally. It explores for nickel and copper deposits. It holds 100% interest in the Nyanga Magmatic nickel copper project with two exploration licenses covering an area of approximately 2,725 square kilometers located in Southern Gabon. The company also has an agreement to acquire 80% interest in the Bend Nickel Project that covers an area of approximately 12 square kilometers located in Zimbabwe. It holds River Gallium-Germanium project located in New England Fold Belt of New South Wales, Australia. The company was formerly known as Rapid Lithium Limited and changed its name to Rapid Critical Metals Limited in May 2025. Rapid Critical Metals Limited was incorporated in 2021 and is based in Sydney, Australia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Rapid Critical Metals Limited (RCM) undervalued?
What is the fair value of RCM?
What is the quality score of RCM?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.